文献速递神经肿瘤

恶性脑肿瘤荧光引导手术可及性改善:头灯放大镜系统联合通用5-氨基乙酰丙酸替代显微镜——一项单中心可行性研究

Improved Availability of Fluorescence-Guided Surgery of Malignant Brain Tumors: A Headlamp-Loupe System Combined With Generic 5-Aminolevulinic Acid Replaces the Microscope-A Monocentric Feasibility Study.
PubMed 文献 · World Neurosurg · 2025-04-09

该单中心可行性研究纳入198例需荧光引导手术的病变患者,由3名神经肿瘤外科医生在头灯放大镜系统(HLLS)与显微镜间选择。206例手术中194例(94%)选用HLLS,无中转显微镜。作者所在中心已从显微镜转向放大镜行荧光引导手术。

要点

  • 206例手术中194例(94%)术者选择头灯放大镜系统(HLLS),无中转显微镜。
  • HLLS可见而显微镜未见的3处不同PpIX荧光强度活检点分别对应正常脑组织、浸润区和高度富细胞肿瘤组织。
  • 作者所在中心已从显微镜转向放大镜行荧光引导手术。

核心结论

  • 作者所在中心通过从显微镜转向放大镜改变了荧光引导手术的实践方式。
  • 作者认为所报告的经验可能对荧光引导手术的普遍使用和可及性产生重要影响,因HLLS和自制5-氨基乙酰丙酸的成本仅为常用方法的一小部分。

研究设计与样本

  • 单中心可行性研究,纳入提示需荧光引导手术的病变患者。
  • 手术由3名专职神经肿瘤外科医生完成,术者可使用头灯放大镜系统(HLLS,即5-氨基乙酰丙酸头灯联合术者适配放大镜,3.5倍,定制佩戴)。
  • 记录术者在HLLS与显微镜之间的选择并对陈述进行半定量分析。
  • 另对1例中不同原卟啉IX(PpIX)荧光强度的特异性与敏感性进行组织病理学评估。

主要发现

  • 共报告198例患者的206例手术。
  • 术者在194例(94%)中选择HLLS,任何病例均未从HLLS中转至显微镜。
  • HLLS可见而显微镜未见的3处PpIX荧光阴性、弱阳性和强阳性区域活检分别对应正常脑组织(PpIX荧光阴性)、浸润区(PpIX荧光弱阳性)和伴微血管增生的高度富细胞肿瘤组织(PpIX荧光强阳性)。

临床怎么用

  • 作者所在中心已从显微镜转向放大镜行荧光引导手术。
  • 作者认为HLLS联合自制5-氨基乙酰丙酸的成本仅为常用方法的一小部分,所报告经验可能对荧光引导手术的普遍使用和可及性产生重要影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Until recently, a prerequisite for fluorescence-guided surgery (FGS) was the use of a specialized microscope. With the availability of a system that combines surgical loupes with an FGS-enabled headlamp, the standard approach to FGS of gliomas is challenged. We therefore investigated the potential change in practice of FGS for gliomas, if the surgeon had the choice between both systems. METHODS: Patients with a lesion indicating FGS were included. Surgery was performed by 3 specialized neurooncological neurosurgeons, who were provided with a headlamp-loupe system (HLLS) (5-aminolevulinic acid headlamp and surgeon-adapted loupes, 3.5X, customized fitted). We recorded surgeons' choice between HLLS and microscope and semi-quantified the statements. Additionally, in one case, specificity and sensitivity of various protoporphyrin IX (PpIX) fluorescence (PpIX-f) were histopathologically evaluated. RESULTS: We report 206 procedures in 198 patients. Surgeons opted in 194 (94%) of the cases for HLLS and did not switch from HLLS to microscope in any case. Three biopsies taken from areas with negative, faint, and highly positive PpIX-f, as revealed by the HLLS but not by the microscope, corresponded to normal brain tissue (negative PpIX-f), infiltration zone (faint PpIX-f), and highly cellular tumor tissue with microvascular proliferation (strong PpIX-f). CONCLUSIONS: Our center changed the practice of FGS by switching from microscopes to loupes. The reported experience might have an important impact on the general use and availability of FGS, as the HLLS and the in-house preparation of 5-aminolevulinic acid come at a fraction of the costs of the commonly practiced approach.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sabel M, Staub-Bartelt F, Tödter J, et al. Improved Availability of Fluorescence-Guided Surgery of Malignant Brain Tumors: A Headlamp-Loupe System Combined With Generic 5-Aminolevulinic Acid Replaces the Microscope-A Monocentric Feasibility Study. World Neurosurg. 2025. PMID: 40216308. doi:10.1016/j.wneu.2025.123967

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。